FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Branko Chorvath

Research Profile

Anatomy

Physiology

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jozef Duraj; Jan Sedlak; Juraj Bies; Jana Chovancova; Branko Chorvath
PSC 833 modulation of multidrug resistance to paclitaxel in cultured human ovarian carcinoma cells leads to apoptosis.
Jana Jakubikova; Jozef Duraj; L Hunakova; Branko Chorvath; Jan Sedlak
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Jozef Duraj; X Takacsova; Jan Sedlak; M Sulikova; L Hunakova; Juraj Bies; Branko Chorvath
PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Branko Chorvath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Jozef Duraj; Jan Sedlak; Juraj Bies; Jana Chovancova; Branko Chorvath
PSC 833 modulation of multidrug resistance to paclitaxel in cultured human ovarian carcinoma cells leads to apoptosis.
Anticancer research 2002;22(6A):3425-8.
2002: Jana Jakubikova; Jozef Duraj; L Hunakova; Branko Chorvath; Jan Sedlak
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Neoplasma 2002;49(4):231-6.
2000: Jozef Duraj; X Takacsova; Jan Sedlak; M Sulikova; L Hunakova; Juraj Bies; Branko Chorvath
PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.
Anticancer research 2000;20(6B):4627-32.
1998: Jan Sedlak; L Hunakova; M Chorvath; M Sulikova; Ladislav Novotny; E Boljesikova; Robert Zeillinger; Branko Chorvath
Resistance of human multidrug-resistant neoplastic cell lines to paclitaxel-induced-radiosensitization is reduced by the non-immunosuppressive cyclosporine analog SDZ PSC 833.
Anticancer research 1998;18(4C):3099-105.
1997: Branko Chorvath; Jan Sedlak; Ladislav Novotny; L Hunakova; E Boljesikova; L Sevcikova; M Chorvath
Non-immunosuppressive cyclosporine derivative PSC 833 abolishes resistance of human multidrug-resistant ovarian carcinoma cells in vitro to paclitaxel and paclitaxel-induced radiosensitization.
International journal of cancer. Journal international du cancer 1997;72(5):916-7.
1995: Jan Sedlak; M Reinerova; L Hunakova; Christoph Ausch; Branko Chorvath; H Rosen; C Moroz
Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines.
Cancer letters 1995;94(1):101-6.
1995: Jozef Duraj; M Kovacikova; Jan Sedlak; J Koppel; A Sobel; Branko Chorvath
The protein kinase C inhibitor H7 blocks phosphorylation of stathmin during TPA-induced growth inhibition of human pre-B leukemia REH6 cells.
Leukemia research 1995;19(7):457-61.
1995: Jan Sedlak; L Hunakova; Jozef Duraj; Branko Chorvath; Ladislav Novotny
Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines.
Anti-cancer drugs 1995;6(1):70-6.
1994: Jan Sedlak; Jozef Duraj; L Hunakova; Branko Chorvath
Expression and alterations of CD66 antigen by interferon-gamma in human breast carcinoma cell lines.
Anticancer research 1994;14(6B):2473-6.
1994: Jan Sedlak; P Speiser; L Hunakova; Jozef Duraj; Branko Chorvath
Modulation of EGF receptor and CD15 (Lewisx) antigen on the cell surface of breast carcinoma cell lines induced by cytokines, retinoic acid, 12-O-tetradecanoylphorbol 13-acetate and 1,25(OH)2-vitamin D3.
Chemotherapy 1994;40(1):51-6.